Coverage
-
November 21, 2013
A third-party drug purchaser told a Pennsylvania federal judge on Wednesday that its class action alleging GlaxoSmithKline PLC subsidized illegal copayments for brand-name prescription drugs was legitimate, arguing that the pharmaceutical giant had no grounds to seek its dismissal.
1 other articles on this case.
View all »